Cortigent, Inc. has a Form S-1 registration statement on file for an initial public offering; the original was filed before the period this page covers, and the earliest filing here is an amendment filed on 2024-08-16. Amendments on record here: 9. As of its latest filing, on 2026-05-13, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have applied to have our common stock listed on NYSE American (“NYSE”) under the symbol “CRGT”.From the S-1/A filed 2026-05-13
Use of proceeds
We intend to use net proceeds from this offering primarily to conduct Orion research studies, convert the Orion prototype into a market-ready device for use in the pivotal clinical trial, conduct research for and initiate an early feasibility study of our Stroke Recovery System, manufacture Orion and stroke recovery devices for clinical studies, and to repay amounts owed to our parent Vivani and for working capital.From the S-1/A filed 2026-05-13
Net loss or income
For the three months ended March 31, 2026 and the fiscal years ended December 31, 2025 and 2024, Cortigent generated no revenue from operations and incurred a net loss of $0.8 million, $3.1 million and $2.2 million, respectively.From the S-1/A filed 2026-05-13
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-08-16 | Registration statement amended | S-1/A |
| 2024-09-04 | Registration statement amended | S-1/A |
| 2024-11-20 | Registration statement amended | S-1/A |
| 2024-12-11 | Registration statement amended | S-1/A |
| 2025-12-02 | Registration statement amended | S-1/A |
| 2026-01-09 | Registration statement amended | S-1/A |
| 2026-03-03 | Registration statement amended | S-1/A |
| 2026-03-17 | Registration statement amended | S-1/A |
| 2026-05-13 | Registration statement amended | S-1/A |
Tools for this story
Each opens in a new tab, filled in for Cortigent, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.